|
🐜
|
BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer.
22 auth.
Mingzhao Xing,
W. Westra,
R. Tufano,
Y. Cohen,
E. Rosenbaum,
K. Rhoden,
K. Carson,
V. Vasko,
A. Larin,
G. Tallini,
...
Sara Tolaney,
E. Holt,
P. Hui,
C. Umbricht,
S. Basaria,
Marge Ewertz,
A. Tufaro,
J. Califano,
M. Ringel,
M. Zeiger,
D. Sidransky,
P. Ladenson
|
9 |
2005 |
9
🐜
|
|
🐜
|
Association between BRAF V600E mutation and recurrence of papillary thyroid cancer.
28 auth.
Mingzhao Xing,
A. Alzahrani,
K. Carson,
Y. Shong,
Tae Yong Kim,
D. Viola,
R. Elisei,
B. Bendlova,
L. Yip,
C. Mian,
F. Vianello,
R. Tuttle,
E. Robenshtok,
J. Fagin,
E. Puxeddu,
...
L. Fugazzola,
A. Czarniecka,
B. Jarzab,
C. O'Neill,
M. Sywak,
A. Lam,
G. Riesco-Eizaguirre,
P. Santisteban,
H. Nakayama,
R. Clifton-Bligh,
G. Tallini,
E. Holt,
V. Sykorova
|
8 |
2015 |
8
🐜
|
|
🐜
|
Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants.
48 auth.
Xiaoguang Shi,
Rengyun Liu,
F. Basolo,
R. Giannini,
Xiaopei Shen,
D. Teng,
H. Guan,
Z. Shan,
W. Teng,
T. Musholt,
K. Al-Kuraya,
L. Fugazzola,
C. Colombo,
E. Kebebew,
B. Jarzab,
...
A. Czarniecka,
B. Bendlova,
V. Sykorova,
M. Sobrinho-Simões,
P. Soares,
Y. Shong,
Tae Yong Kim,
Sonia Cheng,
S. Asa,
D. Viola,
R. Elisei,
L. Yip,
C. Mian,
F. Vianello,
Yangang Wang,
Shi-hua Zhao,
Gisele Oler,
J. Cerutti,
E. Puxeddu,
Shen Qu,
Qing Wei,
Huixiong Xu,
C. O'Neill,
M. Sywak,
R. Clifton-Bligh,
A. Lam,
G. Riesco-Eizaguirre,
P. Santisteban,
Hongyu Yu,
G. Tallini,
E. Holt,
V. Vasko,
Mingzhao Xing
|
7 |
2016 |
7
🐜
|
|
🐜
|
Parathyroidectomy improves neurocognitive deficits in patients with primary hyperparathyroidism.
9 auth.
S. Roman,
J. Sosa,
L. Mayes,
Eric Desmond,
L. Boudourakis,
Rong Lin,
...
P. Snyder,
E. Holt,
R. Udelsman
|
6 |
2005 |
6
🐜
|
|
🐜
|
Follicular Variant of Papillary Thyroid Carcinoma: Accuracy of FNA Diagnosis and Implications for Patient Management
8 auth.
Berrin Ustun,
D. Chhieng,
M. Prasad,
E. Holt,
L. Hammers,
T. Carling,
...
R. Udelsman,
Adebowale J. Adeniran
|
5 |
2014 |
5
🐜
|
|
🐜
|
Risk stratification in follicular neoplasm: A cytological assessment using the modified bethesda classification
7 auth.
Berrin Ustun,
D. Chhieng,
A. Dyke,
T. Carling,
E. Holt,
R. Udelsman,
...
Adebowale J. Adeniran
|
4 |
2014 |
4
🐜
|
|
🦁
|
Care of the pregnant thyroid cancer patient
E. Holt
|
4 |
2010 |
4
🦁
|
|
🐜
|
Adjuvant external beam radiotherapy for surgically resected, nonmetastatic anaplastic thyroid cancer
14 auth.
N. Saeed,
J. Kelly,
H. Deshpande,
A. Bhatia,
B. Burtness,
B. Judson,
S. Mehra,
Heather A. Edwards,
W. Yarbrough,
P. R. Peter,
...
E. Holt,
R. Decker,
Z. Husain,
Henry S. Park
|
3 |
2020 |
3
🐜
|
|
🦁
|
Parathyroid Hormone, Parathyroid Hormone–Related Protein, and Calcitonin
E. Holt,
J. Wysolmerski
|
3 |
2011 |
3
🦁
|
|
🦁
|
Controversies in the surveillance of patients with well differentiated thyroid cancer
E. Holt
|
3 |
2007 |
3
🦁
|
